SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
  
 Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
(Last) (First) (Middle)
1 GUSTAVE L. LEVY PLACE
(Street)
NEW YORK NY 10029
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Renalytix plc [ RNLX ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director X 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
11/01/2024
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
Form filed by One Reporting Person
X Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Ordinary Shares 11/01/2024 J 13,366,750(1) A $0.116(2) 32,683,998 D(3)(4)
American Depositary Shares 2,331,239(5) D(4)(6)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
1. Name and Address of Reporting Person*
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
(Last) (First) (Middle)
1 GUSTAVE L. LEVY PLACE
(Street)
NEW YORK NY 10029
(City) (State) (Zip)
Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
MOUNT SINAI HEALTH SYSTEM, INC.
(Last) (First) (Middle)
150 EAST 42ND STREET
SUITE 2-B.17
(Street)
NEW YORK NY 10017
(City) (State) (Zip)
Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
MOUNT SINAI HOSPITAL
(Last) (First) (Middle)
1 GUSTAVE L. LEVY PLACE
(Street)
NEW YORK NY 10029
(City) (State) (Zip)
Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
1. Name and Address of Reporting Person*
MOUNT SINAI HOSPITALS GROUP, INC.
(Last) (First) (Middle)
1 GUSTAVE L. LEVY PLACE
(Street)
NEW YORK NY 10029
(City) (State) (Zip)
Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
Explanation of Responses:
1. On November 1, 2024, Icahn School of Medicine at Mount Sinai ("ISMMS") acquired 13,366,750 Ordinary Shares of the Issuer in a private placement of the Issuer (the "Private Placement") pursuant to the Subscription Letter dated as of September 30, 2024, after the Issuer's receipt of the requisite shareholder approval. In connection with the Private Placement, the Issuer, in two tranches, issued (a) an aggregate of 92,773,922 Ordinary Shares pursuant to a Placing Agreement with Oberon Investments Limited, (b) an aggregate of 38,387,634 Ordinary Shares (including the Ordinary Shares issued to ISMMS) to certain investors pursuant to Subscription Letters, and (c) an aggregate of 36,550,543 Ordinary Shares as a result of the restructuring of certain convertible bonds.
2. ISMMS acquired the Ordinary Shares for approximately $1.55 million, which is equivalent to a price of 9 pence per Ordinary Share (or approximately $0.116 per share based on a conversion rate of 1 GBP to $1.2920 on November 1, 2024).
3. The securities reported herein are held directly by ISMMS.
4. As the sole member of The Mount Sinai Hospital ("MSH"), Mount Sinai Hospitals Group, Inc. ("MSHG") may be deemed to beneficially own the securities held by MSH. As the sole member of MSHG, Mount Sinai Health System, Inc. ("MSHS") may be deemed to beneficially own the securities beneficially owned by MSHG. As the sole member of ISMMS, MSHS may be deemed to beneficially own the securities held by ISMMS. Each of the reporting persons disclaims beneficial ownership of all such securities reported herein, except to the extent of its pecuniary interest, if any.
5. Each American Depositary Share of the Issuer represents two Ordinary Shares of the Issuer.
6. 948,750 American Depositary Shares are held directly by MSH and 1,382,489 American Depositary Shares are held directly by ISMMS.
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI By: /s/ Vincent Tammaro, Chief Financial Officer 11/05/2024
THE MOUNT SINAI HOSPITAL By: /s/ Vincent Tammaro, Chief Financial Officer 11/05/2024
MOUNT SINAI HEALTH SYSTEM, INC. By: /s/ Vincent Tammaro, Chief Financial Officer 11/05/2024
MOUNT SINAI HOSPITALS GROUP, INC. By: /s/ Vincent Tammaro, Chief Financial Officer 11/05/2024
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Renalytix (PK) (USOTC:RTNXF)
Gráfico Histórico do Ativo
De Out 2024 até Nov 2024 Click aqui para mais gráficos Renalytix (PK).
Renalytix (PK) (USOTC:RTNXF)
Gráfico Histórico do Ativo
De Nov 2023 até Nov 2024 Click aqui para mais gráficos Renalytix (PK).